HBM Healthcare Investments Invests USD 4.5 Million in Lycia Therapeutics IPO
Bitget2026/10/26 05:45- HBM Healthcare Investments invested USD 4.5 million in Lycia Therapeutics' IPO, bringing its total investment to USD 13.5 million.
- Its initial USD 9 million investment came in June 2026 through Series D financing; its post-IPO stake is approximately 2.2%.
- The stake was valued at USD 36.8 million at the first-day closing price of USD 30, up 66.7% from the IPO price.
- Lycia raised gross proceeds of USD 317.5 million by issuing 17,640,000 new shares at USD 18 each.
- Shares began trading on the Nasdaq Global Select Market on October 23, 2026, under the ticker LYCA.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Jim Cramer Waits for Capitulation as AI Funding Worries Hit Tech Stocks
Euro: Upside bias toward 1.1250 against US Dollar – UOB
Australian Dollar regains ground as Democrats eye victory in both Houses
AI infrastructure demand surges, Arista’s revenue growth sets ten-year record since listing, shares soar 10% after hours
Arista Networks has delivered its most impressive quarterly report since its IPO ten years ago: third-quarter revenue surged 58.5% year-on-year to $3.66 billion, marking the fastest annual growth since its IPO in 2014. This signifies that AI-driven demand for network infrastructure has entered an accelerated release phase. Additionally, fourth-quarter guidance is set at a midpoint of $3.95 billion, surpassing analysts’ previous expectations of $3.6 billion.
Crypto prices
More
